Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNA-seq assessment of the impact of anti-IL6R and anti-OSM in a model of fibrotic lung disease during resolution (day 24) [NGS4659]

ABSTRACT: To determine at the single-cell level the transcriptional impact in the immune, stromal, endothelial and epithelial cell populations in the lung of IL-6 and/or OSM signaling in the bleomycin-induced model of lung injury and fibrosis (day 24).

ORGANISM(S): Mus musculus

PROVIDER: GSE263042 | GEO | 2026/01/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

scRNA-seq assessment of the impact of anti-IL6R and anti-OSM in a model of fibrotic lung disease during fibrosis (day 14) [NGS4272]

Project description:To determine at the single-cell level the transcriptional impact in the immune, stromal, endothelial and epithelial cell populations in the lung of IL-6 and/or OSM signaling in the bleomycin-induced model of lung injury and fibrosis (day 14).

2026-01-06 | GSE263041 | GEO

Determining the impact of anti-IL6 and anti-OSM on macrophage and fibroblast biology in a model of fibrotic lung disease [NGS3341]

Project description:To determine the comparative effect of anti-IL6 and anti-OSM treatment in lung fibrosis, mice received saline or bleomycin via instillation and then received antibodies via intraperitoneal injection once weekly until take down. At day 14, mice were euthanized, lungs were isolated and lysed in RLT buffer. Total RNA was extracted and sequenced by bulk RNA-sequencing.

2026-01-06 | GSE262966 | GEO

scRNA-seq assessment of the impact of anti-IL6R and anti-OSM in a model of fibrotic lung disease during resolution (day 24) [NGS4659]

Project description:scRNA-seq assessment of the impact of anti-IL6R and anti-OSM in a model of fibrotic lung disease during resolution (day 24) [NGS4659]

| PRJNA1095508 | ENA

scRNA-seq assessment of the impact of anti-IL6R and anti-OSM in a model of fibrotic lung disease during fibrosis (day 14) [NGS4272]

Project description:scRNA-seq assessment of the impact of anti-IL6R and anti-OSM in a model of fibrotic lung disease during fibrosis (day 14) [NGS4272]

| PRJNA1095510 | ENA

Assessment of OSMR dependency in normal human lung fibroblasts [NGS4564]

Project description:To investigate OSMR dependency in normal human lung fibroblasts, cells were preincubated with anti-OSM, or (one of 2) anti-OSMR, or anti-OSM+anti-OSMR antibodies, then stimulated with OSM or PBS for 24 hours.

2026-01-06 | GSE262967 | GEO

RNA-sequencing comparison of pneumonectomy and bleomycin reveals novel anti-fibrotic mechanisms and regulators

Project description:Fibroblast activation is transient in successful wound repair, but persistent in fibrotic pathologies. Understanding fibroblast deactivation during successful wound healing may provide new approaches to therapeutically reverse fibrogenic cell activation. To characterize the gene programs that accompany fibroblast activation and reversal during lung fibrosis resolution, we used RNA-seq analysis of flow-sorted Col1α1-GFP positive and CD45, CD31, and CD326 negative cells isolated from the lungs of young mice exposed to bleomycin and pneumonectomy. We compared fibroblasts isolated from controls to those isolated at days 14 and 30 after bleomycin exposure, as well as at 14 days after pneumonectomy, representing the peak of extracellular matrix deposition, early stage of fibrosis resolution, and non-fibrotic lung repair respectively.

2020-11-13 | GSE161322 | GEO

Oncostatin M (OSM) and Leukemia Inhibitory factor (LIF) treatment of osteoblasts via LIF and OSM receptors

Project description:Oncostatin M (OSM) and Leukemia Inhibitory Factor (LIF) signal within cells via the gp130 (Il6st) coreceptor bound either to the LIF receptor (LIFR) or the oncostatin M receptor (OSMR), but whether murine OSM can act through both receptors is controversial. Both LIF and OSM stimulate bone formation, inhibit adipocyte differentiation, and promote osteoclast differentiation, but our earlier work suggested this may depend on the receptor subtype used. This project aimed to identify those gene targets regulated by murine OSM via OSMR and LIFR by using wild type and OSMR null primary osteoblasts. Cells were differentiated to their most mature state (i.e. osteocytes) because the only prior target gene known to be regulated by murine OSM via the LIFR was an osteocyte-specific gene, sclerostin.

2016-08-17 | GSE83418 | GEO

Heterocellular OSM-OSMR signalling drives pancreatic tumour growth and metastasis through functional fibroblast reprogramming

Project description:Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy characterised by a pathologicalfibroinflammatorymicroenvironment. Dichotomous tumour-promoting and -restrictive roles have been ascribed to the tumour microenvironment, however thedisparate effect of individual stromal subsets remains incompletely characterised. Here, we describe how heterocellular OSM-OSMR signalling instructsfibroblast reprogramming,tumourgrowth and metastasis.Macrophage-secreted OSM stimulatesinflammatory gene expression in cancer-associated fibroblasts (CAFs), which in turn induce a pro-tumorigenic environment and engage tumour cellsurvival and migratory signalling pathways. Tumour cells implanted in Osm-deficient (Osm-/-) mice display an epithelial-dominated morphology, reduced tumour growth and did notmetastasise. Moreover, the tumour microenvironment of Osm-/-animals exhibit increased abundance of αSMAposmyofibroblasts and a shift in myeloid and T cell phenotypes, consistent with a more immunogenic environment. Taken together, these data demonstrate how OSM-OSMR signalling coordinates heterocellular interactions to drive a pro-tumorigenic environment in PDA.

2021-11-29 | PXD022484 | Pride

Gene expression of HCT116 cells after stimulation with oncostatin M (OSM)

Project description:To evaluate gene expression profiles in intestinal epithelial cells (IEC) after OSM stimulation, we have employed whole genome microarray expression profiling as a discovery platform to identify relevant genes which are potentially of interest to reveal the role of OSM in intestinal inflammation. The most strongly up-regulated genes were SERPINS, which belong to the family of serin peptidase inhibitors with antiprotease activities, most of them serine and cysteine proteases. SERPINB4, SERPINB3 and SERPINA3 were the genes with the strongest up-regulation, also verified in qPCR. OSM-induced SERPIN up-regulation may contribute to anti-apoptotic and proliferative effects of OSM in IEC. HCT116 cells were starved overnight with medium containing 1% FCS after reaching 70% confluency. On the next day, cells were stimulated in quadruplicates with 100 ng/mL OSM or left unstimulated. RNA was isolated 6 hours after stimulation and RNA concentration and purity was measured.

2014-12-13 | E-GEOD-53295 | biostudies-arrayexpress

Expression data from cancer associated fibroblasts (CAFs) treated with OSM

Project description:The cytokine Oncostatin M (OSM) promotes cancer progression by acting as central node for multicellular interactions between cancer cells and surrounding stromal cells. OSM is mainly secreted by myeloid cells and the oncostatin M receptor (OSMR) is expressed by cancer cells and cancer associated fibroblasts (CAFs), among others. To understand the effect of OSM in CAFs, a small and well-annotated Clariom S gene microarray was performed in CAF-173 cells cultured in 3D spheroids and treated with OSM or vehicle (PBS).

2022-02-02 | GSE195775 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data